Loading…

An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines

The Autotransporter pathway, ubiquitous in Gram-negative bacteria, allows the efficient secretion of large passenger proteins via a relatively simple mechanism. Capitalizing on its crystal structure, we have engineered the Escherichia coli autotransporter Hemoglobin protease (Hbp) into a versatile p...

Full description

Saved in:
Bibliographic Details
Published in:Microbial cell factories 2014-11, Vol.13 (1), p.162-162, Article 162
Main Authors: Jong, Wouter S P, Daleke-Schermerhorn, Maria H, Vikström, David, Ten Hagen-Jongman, Corinne M, de Punder, Karin, van der Wel, Nicole N, van de Sandt, Carolien E, Rimmelzwaan, Guus F, Follmann, Frank, Agger, Else Marie, Andersen, Peter, de Gier, Jan-Willem, Luirink, Joen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Autotransporter pathway, ubiquitous in Gram-negative bacteria, allows the efficient secretion of large passenger proteins via a relatively simple mechanism. Capitalizing on its crystal structure, we have engineered the Escherichia coli autotransporter Hemoglobin protease (Hbp) into a versatile platform for secretion and surface display of multiple heterologous proteins in one carrier molecule. As proof-of-concept, we demonstrate efficient secretion and high-density display of the sizeable Mycobacterium tuberculosis antigens ESAT6, Ag85B and Rv2660c in E. coli simultaneously. Furthermore, we show stable multivalent display of these antigens in an attenuated Salmonella Typhimurium strain upon chromosomal integration. To emphasize the versatility of the Hbp platform, we also demonstrate efficient expression of multiple sizeable antigenic fragments from Chlamydia trachomatis and the influenza A virus at the Salmonella cell surface. The successful efficient cell surface display of multiple antigens from various pathogenic organisms highlights the potential of Hbp as a universal platform for the development of multivalent recombinant bacterial vector vaccines.
ISSN:1475-2859
1475-2859
DOI:10.1186/s12934-014-0162-8